MULTIPLE PREGNANCIES AFTER INTRACYTOPLASMIC SPERM INJECTION (ICSI)
Abstract
Background. Because of complications related to multiple pregnancies after in vitro fertilization this pathology represent a real problem. Intracytoplasmic sperm injection (ICSI) may lead to higher risk in developing monozygotic pregnancies. We sought to investigate whether the multiple pregnancies after ICSI differ of those consecutive to classical in vitro fertilization (IVF) and if counseling for transfering one or at most two embryos is efficient in preventing multiple pregnancies.
Methods. We analyzed retrospectively data concerning the incidence of multiple pregnancies before and after the transfer of limited number of embryos.
Results. In transfering two cleaving-stage embryos (day 2) or blastocysts (day 5), when pregnancy rate is high, the incidence of multiple pregnancies is 25 and 17%. After transfer of one blastocyst the highest the pregnancy rate and the lowest the incidence of multiple pregnancies.
Conclusions. The best way to avoid multiple pregnancies consist in transferring one or at most two embryos. The monozygotic twin pregnancy we observed was consecutive to the transfer of frozen-thawed blastocyst.
Downloads
References
Palermo GD, Colombero LT, Schattman GL, Dawis KO, Rosenwaks Z. Evolution of pregnancies and initial follow-up of newborns delivered after intracytoplasmic sperm injection. JAMA 1996; 346: 1893–7.
Wennerholm UB, Bergh C, Hamberger L, Westlander G, Wikland M, Wood M. Obstetric outcome of pregnancies following ICSI, classified according to sperm origin and quality. Hum Reprod 2000; 15: 1189–94.
Zorn B, Virant-Klun I, Drobnič S et al. Pregnancies and children after intracytoplasmic sperm injection attempt at the department of obstetrics and gynecology in Ljubljana. Retrospective study after the birth of 101 children. Zdrav Vestn 2000; 69: 67–73.
Monset-Couchard M, de Betmann O, Relier JP. Neonatal outcome from assisted reproductive technologies. Gynaecol Perinatol 1998; 7: 59–62.
Martikainen H, Tiitinen A, Tomás C et al. One versus two embryo transfer after IVF and ICSI: a randomized study. Hum Reprod 2001; 16: 1900–3.
Gerris J, de Neubourg D, Mangelschots K, van Royen E, van der Meerssche M, Valkenburg M. Prevention of twin pregnancies of in-vitro fertilization or ICSI based on strict criteria: a prospective randomized clinical trial. Hum. Reprod 1999; 14: 2581–7.
Gardner DK, Lane M, Stevens J, Schenker T, Schoolcraft WB. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril 2000; 73: 1155–8.
Yovich JL, Stanger JD, Gravaug A et al. Monozygotic twins from in vitro fertilization. Fertil Steril 1984; 41: 833–7.
Tarlatzis BC, Qublan HS, Sanopoulou T, Zepiridis L, Grimbizis G, Bontis J. Increase in the monozygotic twinning rate after intracytoplasmic sperm injection and blastocyst stage embryo transfer. Fertil Steril 2002; 77: 196–8.
Alikani M, Noyes N, Cohen J, Rosenwaks Z. Monozygotous twinning in human is associated with the zona pellucida architecture. Hum Reprod 1994; 9: 1318–21.
Rijnders PM, van Os HC, Jansen CAM. Increased incidence of monozygotic twinning following the transfer of blastocysts in human IVF/ICSI. Fertil Steril 1998; 70: Suppl 1: 15S–16S.
Milki AA, Jun SH, Hinckley MD, Behr B, Giudice LC, Westphal LM. Incidence of monozygotic twinnings with blastocyst transfer compared to cleavagestage transfer. Fertil Steril 2003; 79: 503–6.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.